doi: 10.1038/d41586-022-02869-4pmid: 36171372
Drugs under development offer the mental-health benefits of psilocybin and similar substances without inducing strong hallucinatory effects.
doi: 10.1038/d41586-022-02869-4pmid: 36171372
Drugs under development offer the mental-health benefits of psilocybin and similar substances without inducing strong hallucinatory effects.
doi: 10.1038/d41586-022-02874-7pmid: 36171369
Mind-altering drugs are shaking up medicine — but how they actually work remains a mystery. A flurry of imaging studies could clarify the picture.
doi: 10.1038/d41586-022-02868-5pmid: 36171371
Mind-bending drugs are entering the therapeutic arena
doi: 10.1038/d41586-022-02871-wpmid: 36171365
Gül Dölen explains how psychedelics restore the brain’s capacity for plasticity, which fades with age, and make possible new mental-health therapies.
Zingg, Daniel; Bhin, Jinhyuk; Yemelyanenko, Julia; Kas, Sjors M.; Rolfs, Frank; Lutz, Catrin; Lee, Jessica K.; Klarenbeek, Sjoerd; Silverman, Ian M.; Annunziato, Stefano; Chan, Chang S.; Piersma, Sander R.; Eijkman, Timo; Badoux, Madelon; Gogola, Ewa; Siteur, Bjørn; Sprengers, Justin; de Klein, Bim; de Goeij-de Haas, Richard R.;
doi: 10.1038/d41586-022-02878-3pmid: 36171363
Drugs best known for their hallucinogenic properties, such as psilocybin, could help people beat the agony of migraines and other painful maladies.
Alvarez, Samantha W.; Sviderskiy, Vladislav O.; Terzi, Erdem M.; Papagiannakopoulos, Thales; Moreira, Andre L.; Adams, Sylvia; Sabatini, David M.; Birsoy, Kıvanç; Possemato, Richard
doi: 10.1038/s41586-022-05323-7pmid: 36104569
Gu, Xin; Jouandin, Patrick; Lalgudi, Pranav V.; Binari, Rich; Valenstein, Max L.; Reid, Michael A.; Allen, Annamarie E.; Kamitaki, Nolan; Locasale, Jason W.; Perrimon, Norbert; Sabatini, David M.
doi: 10.1038/d41586-022-02875-6pmid: 36171366
Clinical trials of psychedelic drugs impose constraints that make it difficult to judge how effective they will be in treating people.
doi: 10.1038/d41586-022-02870-xpmid: 36171367
Some researchers are finding clues that MDMA might be able to treat post-traumatic stress disorder. But the science has yet to catch up with the optimism.
Showing 1 to 10 of 68 Articles
doi: 10.1038/s41586-022-05287-8pmid: 36050473